Trial intelligence / Profile preview

Ultrasound Guided Nerveblocks for Persistent Pain After Breast Cancer Surgery

NCT02336529Phase 3Unknown

Start
Jul 2016
Primary completion
Jul 2017
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial of bupivacaine in neuropathic pain (4 arms). Primary endpoint: Summed pain intensity. Status: unknown.

02

Drugs

bupivacaine
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT02336529.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02336529.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call